Singh Shawn (CIK 0001412071)

Latest company ownership

Shares held
20,875
Last filed at
Jul 2, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 17, 2022 Aug 18, 2022 Vistagen Therapeutics, Inc. CEO Buy 95.0 +600,000 332.90% ✗ $103.2K